ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2021

Cost-Effectiveness of iGlarLixi Versus iDegLira in Type 2 Diabetes Mellitus Inadequately Controlled by GLP-1 Receptor Agonists and Oral Antihyperglycemic Therapy.

Rory J McCrimmon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.